the most complete clinical comparison to date suggests that , in currently sanctioned doses , a regimen containing both theophylline and an inhaled beta 2 agonist provides significantly greater bronchodilation than either drug alone , with fewer patient withdrawals .
C0039771
theophylline
C1371299
bronchodilation